Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (128)

« Back to Publications

The metabolic balancing act between fatty acid and glucose substrate use for optimal myocardial function: Key role for membrane substrate transporters.

Glatz JFC. et al, (2026), Am J Physiol Heart Circ Physiol

Systems Biology and Functional Assessments of Human iPSC-Cardiomyocyte Models of Insulin Resistance Capture Key Hallmarks of Diabetic Cardiomyopathy.

Carter RD. et al, (2025), Diabetes, 74, 1929 - 1945

Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets.

Mericskay M. et al, (2025), Nat Rev Cardiol, 22, 704 - 727

Oxidative phosphorylation is required for cardiomyocyte re-differentiation and long-term fish heart regeneration.

Lekkos K. et al, (2025), Nat Cardiovasc Res, 4, 1363 - 1380

FoxO1-zDHHC4-CD36 S-Acylation Axis Drives Metabolic Dysfunction in Diabetes.

Dennis KMJH. et al, (2025), Circ Res, 136, 1545 - 1560

Targeting glucose metabolism with dichloroacetate (DCA) reduces zika virus replication in brain cortical progenitors at different stages of maturation.

Gilbert-Jaramillo J. et al, (2024), Antiviral Res, 228

Compartmentalization proteomics revealed endolysosomal protein network changes in a goat model of atrial fibrillation.

Ayagama T. et al, (2024), iScience, 27

ICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats.

Choksey A. et al, (2024), J Mol Cell Cardiol, 191, 12 - 22

Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.

Heather LC. et al, (2024), Diabetes, 73, 659 - 670

CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease.

Glatz JFC. et al, (2024), Physiol Rev, 104, 727 - 764

Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities.

Machado ND. et al, (2023), Br J Cancer, 129, 897 - 899

Cardiomyocyte tetrahydrobiopterin synthesis regulates fatty acid metabolism and susceptibility to ischaemia-reperfusion injury.

Chu SM. et al, (2023), Exp Physiol, 108, 874 - 890

Post-translational palmitoylation of metabolic proteins.

Dennis KMJH. and Heather LC., (2023), Front Physiol, 14

Cardiometabolic risk factors vary with age differently in females and males.

Miller JJ. and Heather LC., (2022), Nat Cardiovasc Res, 1, 796 - 797

Guidelines on models of diabetic heart disease.

Heather LC. et al, (2022), Am J Physiol Heart Circ Physiol, 323, H176 - H200

Load More

1
2
3
4
5
6
7
...
»